Partners Group Faces a Defining Test: A €6bn Refinancing Wall Behind the Fee Slide

Partners Group's shares rebound after drop, but €6B debt at Emeria, Ammega, Breitling and falling performance fees weigh on outlook.

The relief rally in Partners Group's shares on Wednesday — up 3.2 percent to €737.60 — papers over a more uncomfortable reality for the Swiss private-equity house. The bounce follows a bruising 7.26 percent drop on Tuesday after half-year results landed, but investors scanning the detail beneath the headline numbers are increasingly focused on a problem that has nothing to do with fee income: roughly €6 billion of debt coming due at three portfolio companies between 2027 and 2028.

Emeria SASU, Ammega Group and Breitling are the names in question. According to reports from Monday, creditors are pressing for a capital injection of €500 million to €600 million to shore up their balance sheets, with Partners Group weighing a contribution of around €200 million. Fitch has flagged elevated refinancing risk in connection with the situation. For shareholders, this is not a footnote. The firm's earnings are tied not just to management fees but meaningfully to how its underlying investments perform — and distressed portfolio companies translate directly into writedowns and thinner performance fees.

That linkage was already visible in the numbers that triggered Tuesday's sell-off. Group revenue fell 7 percent to CHF 1.12 billion, while performance fees tumbled 39 percent to CHF 216 million. Net profit dropped 13 percent to CHF 502 million. More tellingly, management cut its guidance for the share of performance fees in total 2026 income to 20–25 percent, down from a prior range of 25–40 percent — an acknowledgment that the earnings mix is becoming less predictable than previously assumed.

A Leadership Handover That Isn't the Real Story

Tuesday also brought news of a changing of the guard. David Layton, chief executive since 2019, will step down on January 1, 2027, moving into the roles of chief investment officer and chairman of the Global Investment Committee. Roberto Cagnati and Juri Jenkner are set to take over as co-CEOs. The announcement has likely contributed to Wednesday's recovery, signalling continuity in investment strategy. But for the medium-term valuation of the stock, the refinancing question carries more weight. Should negotiations with creditors at Emeria, Ammega and Breitling stumble — or prove costlier than anticipated — the balance sheet faces further strain. A clean resolution, by contrast, could go some way toward restoring the investor confidence that the half-year figures eroded.

The operational picture is not without momentum, however. Partners Group reaffirmed its full-year guidance for capital commitments of $26 billion to $32 billion, and deal activity continues apace. The firm is in exclusive talks to acquire a majority stake in Aroma-Zone, the French natural cosmetics brand currently owned by Eurazeo, and is pursuing the takeover of AVK Power Solutions, a provider of power-supply infrastructure for data centres, with a planned equity investment of more than $1 billion.

The Bull and Bear Case in One Chart

There are credible arguments on both sides of the ledger. The fundraising engine remains robust: first-half inflows hit a record $16 billion, up 31 percent year on year, lifting assets under management to $186 billion by end-June from $185 billion at the close of 2025. Management fees — the predictable core of the business — grew 6 percent, and the EBITDA margin held steady at 63 percent even as absolute EBITDA slipped 9 percent to CHF 706 million.

The bear case rests on the structure of the model itself. A 39 percent collapse in performance fees over six months is not easily dismissed as a blip, particularly when management's own guidance revision suggests it anticipates continued headwinds — possibly tied to gating measures at mature evergreen funds that were already a topic of discussion over the summer. The leadership transition adds another layer of uncertainty: even with Layton staying on in an investment capacity, the co-CEO duo must prove itself, and markets have historically been skittish about management changes at asset managers where value is closely tied to trust in the people running the show.

What Happens Next

The near-term path for the shares hinges on whether performance fees stabilise in the second half or keep eroding. If further evergreen funds fall into gating situations, the pressure on the valuation will persist regardless of how smoothly the leadership handover proceeds. The first concrete test arrives in January 2027, when the new co-CEOs take office and investors will see whether the acquisition strategy — at AVK Power Solutions, potentially Aroma-Zone, and elsewhere — continues as charted or undergoes correction.

Until then, the resolution of the €6 billion refinancing question at Emeria, Ammega and Breitling may prove the more immediate determinant of where the stock goes from here. A messy outcome would compound the damage from the fee shortfall; an orderly one could give the shares the foundation they currently lack.